Connect with us

COVID-19

595 New Coronavirus Cases Confirmed in Nigeria – NCDC

Published

on

595 New Coronavirus Cases NCDC

595 New Coronavirus Cases Confirmed in Nigeria – NCDC

On Monday, July 13, the Nigeria Centre for Disease Control (NCDC) Confirmed 595 new cases of Coronavirus (COVID-19) across the Country.

 

A breakdown of the new cases across states is as follows; Lagos-156, Oyo-141, FCT-99, Edo-47, Kaduna-27, Ondo-22, Rivers-20, Osun-17, Imo-13, Plateau-10, Nasarawa-8, Anambra-8, Kano-5, Benue-5, Borno-5, Ogun-4, Taraba-3, Gombe-3, Kebbi-1, Cross Rivers-1.

ALSO READ:

There are now 33,153 confirmed cases of Coronavirus in the country and 744 deaths have been recorded. 13,671 patients have also been discharged after recovering from the disease.

Join us on FACEBOOK

COVID-19

U.S Approves Pfizer COVID Booster for The Elderly and High-Risk

Published

on

U.S Approves Pfizer COVID Booster for The Elderly and High-Risk

The U.S has authorised the administration of boosters of the Pfizer-Biontech Covid-19 vaccine for people aged over 65, as well as adults at high risk of severe disease and those in high-exposure jobs.

The announcement means a significant part of the US population – amounting to tens of millions of Americans – are now eligible for a third shot six months after their second.

The decision was expected and came after an independent expert panel convened by the regulatory agency last week voted in favour of recommending the move.

Watch Our Youtube Videos

The panel, however, rejected an initial plan by the white house to fully approve Pfizer boosters for everyone aged 16 and over, in what amounted to a rare rebuke of President Joe Biden’s administration.

Pfizer Covid-19 boosters are currently being debated by a separate body of experts convened by the centers for disease control and prevention, which may recommend further specifics about recipients of the vaccine.

Read Also:

President Biden Pledges 500m More Vaccine Doses to Developing World

Japan Detects More Moderna Vaccine Contamination

 

Continue Reading

COVID-19

India Resumes Export of Covid-19 Vaccine from October

Published

on

India Resumes Export of Covid-19 Vaccine from October

India will resume exporting Covid-19 vaccines from October, five months after it stopped sending supplies abroad in the face of a deadly wave of infections, the health minister said on Monday.

The world’s largest vaccine producer had halted exports in April, when a virus surge in India pushed the healthcare system to breaking point and there was a huge demand for jabs.

Health Minister Mansukh Mandaviya said more than 300 million vaccine doses would be produced in October and one billion in the last three months of the year.

Follow us on Facebook

“India will be resuming export of vaccines in order to fulfill the commitment of India towards Covax. The surplus supply of vaccines will be used to fulfill our commitment towards the world for the collective fight against Covid-19”, Mandaviya said in a statement.

India wants to vaccinate its adult population by the end of 2021. It has given more than 818 million doses of the three approved jabs since the beginning of the vaccination drive in January. On Friday, it administered a record-breaking 20 million doses, surpassing the country’s previous best daily tally of more than 13 million jabs on 27 August.

Read Also:

Court Orders Resident Doctors to Call Off Strike

AU Rolls Out 400m Vaccine Doses to Member States

Continue Reading

COVID-19

Pfizer Says Its Covid-19 Jab Safe for Children Aged 5-11

Published

on

Pfizer Says Its Covid-19 Jab Safe for Children Aged 5-11

Pfizer and Biontech on Monday said trial results showed their Coronavirus vaccine was safe and produced a robust immune response in children aged five to 11, adding that they would seek regulatory approval shortly.

The vaccine would be administered at a lower dosage than for people over 12, they said.

They plan to submit their data to regulatory bodies in the European Union, the united states and around the world “as soon as possible”.

Follow us on Facebook

The trial results are the first of their kind for children under 12, with a Moderna trial for six-11-year-olds still ongoing.

Both the Pfizer and Moderna jabs are already being administered to adolescents over 12 and adults in countries around the globe.

Although children are considered less at risk of severe cases of Covid-19, there are concerns that the highly contagious delta variant could lead to more serious cases.

Inoculating children is also seen as key to keeping schools open and helping end the pandemic.

Read Also:

Nigerian Doctor Helps Pfizer Develop First Effective COVID-19 Vaccine

NPHCDA Begins Online Registration Of Nigerians For COVID-19 Vaccination

Continue Reading

Trending